Intraocular use for obtaining miosis during surgery.

In addition, MIOSTAT (carbachol intraocular solution, USP) reduces the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery.

---

Intraocular pressure disorder --

Should not be used in those persons showing hypersensitivity to any of the components of this preparation.

---

Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

For single-dose intraocular use only.

Discard unused portion.

Intraocular carbachol 0.01% should be used with caution in patients with acute cardiac failure, bronchial asthma, peptic ulcer, hyperthyroidism, G.I.

spasm, urinary tract obstruction and Parkinson’s disease.PRECAUTIONSUse only if the container is undamaged.